Afghanistan vs Sudan: Access to anti-retroviral drugs, male
Afghanistan
7.0%
in 2024
Sudan
23.0%
in 2024
Afghanistan rank
141st
Sudan rank
138th
Access to anti-retroviral drugs, male over time
- Afghanistan
- Sudan
How they compare
Sudan currently reports 23.0% against 7.0% in Afghanistan, a difference of 16.0%.
That makes Sudan's figure about 3.3 times Afghanistan's.
Across all 22 years both countries report, Sudan has been ahead every year.
Afghanistan ranks 141st and Sudan ranks 138th of 141 countries.
Sudan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 2.1% | 2.1% | Sudan |
| 2010s | 4.7% | 17.0% | 12.3% | Sudan |
| 2020s | 7.4% | 25.0% | 17.6% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Afghanistan or Sudan?
- Sudan, at 23.0% against 7.0% in Afghanistan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Afghanistan and Sudan?
- 16.0%, with Sudan ahead.
- How many years of comparable data are there for Afghanistan and Sudan?
- 22 years are reported by both, from 2000 to 2024.
- How do Afghanistan and Sudan rank globally for access to anti-retroviral drugs, male?
- Afghanistan ranks 141st and Sudan ranks 138th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.